The median prevalence of arsenicosis was 2.6% in exposed areas.
To date, there have been conflicting data on the prevalence of HPV in primary breast carcinoma, with a median prevalence of 35%.
On the basis of 4 studies with a total of 628 participants across all surgery types, median prevalence of CPSP across studies was 20% (25th percentile = 14.5%, 75th percentile = 38%) at 12 months after surgery.
A recent meta-analysis showed that the median prevalence of DLE was 3.5% of the population, with an inter-quartile range between 1.9 and 14.4% [3].
The median prevalence of having one or more SDRMs in the eight subtypes in our dataset was 1.3% for the NRTIs, 0.5% for the NNRTIs, and 1.1% for the PIs.
The median prevalence of patent parasitemia (≥100 parasites/µl) in the population varied from 1.9 to 2.6% across the simulations, comparable to the median for children aged 4 to 8 years (2.0 2.9%).
The calculated median prevalence of HIV is 4.26% (IQR, 4.19-4.33%) and the median prevalence of chlamydia 2.69% (IQR, 1.68-3.71%) in the MSM population.
The median prevalence of LVSD was 29.9% (inter-quartile range 14%to37%7%).
Intra-farm prevalence ranged from 4.3 to 40%%, with a median prevalence of 5.3%% (Fig. 2).
For both sexes combined, the median prevalence of smoking from published studies is around 30%.
The median prevalence of substandard/counterfeit medicines was 28.5% (range 11 48%).
